•
Dec 31, 2017

Leap Therapeutics Q4 2017 Earnings Report

EPS
-$6.5
Previous year: -$0.58
+1020.7%
Cash and Equivalents
$25.7M
Free Cash Flow
-$6.37M
Total Assets
$29.1M

Leap Therapeutics

Leap Therapeutics